These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 19620839)

  • 1. GCDFP-15 positive and TTF-1 negative primary lung neoplasms: a tissue microarray study of 381 primary lung tumors.
    Wang LJ; Greaves WO; Sabo E; Noble L; Tavares R; Ng T; DeLellis RA; Resnick MB
    Appl Immunohistochem Mol Morphol; 2009 Dec; 17(6):505-11. PubMed ID: 19620839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A study of immunohistochemical differential expression in pulmonary and mammary carcinomas.
    Yang M; Nonaka D
    Mod Pathol; 2010 May; 23(5):654-61. PubMed ID: 20173733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of immunohistochemical markers in primary lung and breast cancers enriched for triple-negative tumours.
    Provenzano E; Byrne DJ; Russell PA; Wright GM; Generali D; Fox SB
    Histopathology; 2016 Feb; 68(3):367-77. PubMed ID: 26118394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GATA-3 is superior to GCDFP-15 and mammaglobin to identify primary and metastatic breast cancer.
    Ni YB; Tsang JYS; Shao MM; Chan SK; Cheung SY; Tong J; To KF; Tse GM
    Breast Cancer Res Treat; 2018 May; 169(1):25-32. PubMed ID: 29340880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can GATA3 Immunocytochemistry be Utilized as a Reliable Diagnostic Marker for Metastatic Breast Carcinoma in Cytological Materials? A Comparative Study with Mammaglobin and GCDFP-15 Expression.
    Hafez NH; Shaaban HM
    Turk Patoloji Derg; 2018; 34(2):143-149. PubMed ID: 29235613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens.
    Yan Z; Gidley J; Horton D; Roberson J; Eltoum IE; Chhieng DC
    Diagn Cytopathol; 2009 Jul; 37(7):475-8. PubMed ID: 19217055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung.
    Hattori Y; Yoshida A; Yoshida M; Takahashi M; Tsuta K
    Pathol Int; 2015 Jun; 65(6):286-92. PubMed ID: 25727644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of estrogen receptor in pulmonary adenocarcinoma.
    Lau SK; Chu PG; Weiss LM
    Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):83-7. PubMed ID: 16540736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 expression in morphologic subtypes of breast carcinoma: a comparison with gross cystic disease fluid protein 15 and mammaglobin.
    Wendroth SM; Mentrikoski MJ; Wick MR
    Ann Diagn Pathol; 2015 Feb; 19(1):6-9. PubMed ID: 25544392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In search of the ideal immunopanel to distinguish metastatic mammary carcinoma from primary lung carcinoma: a tissue microarray study of 207 cases.
    Kawaguchi KR; Lu FI; Kaplan R; Liu YF; Chadwick P; Chen Z; Brogi E; Shin SJ
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):266-74. PubMed ID: 23958551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic utility of PAX8, TTF-1 and napsin A for discriminating metastatic carcinoma from primary adenocarcinoma of the lung.
    Ye J; Hameed O; Findeis-Hosey JJ; Fan L; Li F; McMahon LA; Yang Q; Wang HL; Xu H
    Biotech Histochem; 2012 Jan; 87(1):30-4. PubMed ID: 21838611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of napsin A and TTF-1 immunohistochemistry helps in differentiating primary lung adenocarcinoma from metastatic carcinoma in the lung.
    Ye J; Findeis-Hosey JJ; Yang Q; McMahon LA; Yao JL; Li F; Xu H
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):313-7. PubMed ID: 21464700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
    Chia SY; Thike AA; Cheok PY; Tan PH
    Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of WT1, CA 125, and GCDFP-15 as useful markers in the differential diagnosis of primary ovarian carcinomas versus metastatic breast cancer to the ovary.
    Tornos C; Soslow R; Chen S; Akram M; Hummer AJ; Abu-Rustum N; Norton L; Tan LK
    Am J Surg Pathol; 2005 Nov; 29(11):1482-9. PubMed ID: 16224215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The utility and limitation of thyroid transcription factor-1 protein in primary and metastatic pulmonary neoplasms.
    Chang YL; Lee YC; Liao WY; Wu CT
    Lung Cancer; 2004 May; 44(2):149-57. PubMed ID: 15084379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 by breast cancer: a possible diagnostic application.
    Alsabeh R; Wilson CS; Ahn CW; Vasef MA; Battifora H
    Mod Pathol; 1996 Apr; 9(4):439-44. PubMed ID: 8729986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast.
    Honma N; Takubo K; Akiyama F; Sawabe M; Arai T; Younes M; Kasumi F; Sakamoto G
    Histopathology; 2005 Aug; 47(2):195-201. PubMed ID: 16045781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surfactant proteins and thyroid transcription factor-1 in pulmonary and breast carcinomas.
    Bejarano PA; Baughman RP; Biddinger PW; Miller MA; Fenoglio-Preiser C; al-Kafaji B; Di Lauro R; Whitsett JA
    Mod Pathol; 1996 Apr; 9(4):445-52. PubMed ID: 8729987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of caveolin-1, thyroid transcription factor-1, and cytokeratins 7 and 20 in discriminating between primary and secondary pulmonary adenocarcinoma from breast or colonic origin.
    Tsao SC; Su YC; Wang SL; Chai CY
    Kaohsiung J Med Sci; 2007 Jul; 23(7):325-31. PubMed ID: 17606426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serous papillary adenocarcinoma of the female genital organs and invasive micropapillary carcinoma of the breast. Are WT1, CA125, and GCDFP-15 useful in differential diagnosis?
    Moritani S; Ichihara S; Hasegawa M; Endo T; Oiwa M; Yoshikawa K; Sato Y; Aoyama H; Hayashi T; Kushima R
    Hum Pathol; 2008 May; 39(5):666-71. PubMed ID: 18339419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.